
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Himalayan Gooseberry (Phyllanthus emblica) contains exceptional concentrations of vitamin C and bioactive compounds including ellagic acid, gallic acid, and quercetin that modulate immune function and cellular defense mechanisms. The fruit's polyphenolic compounds activate phase II detoxifying enzymes while suppressing inflammatory markers like COX-2 by up to 46.4% at 10 μg/mL concentrations.

Reported Benefits (Provisional)
Origin & History

The Himalayan Gooseberry (Phyllanthus emblica), also known as Amla, is native to the high-altitude forests and foothills of the Himalayas. This resilient fruit thrives in temperate mountain environments. It is highly prized in traditional medicine for its exceptional nutrient density and broad spectrum of health-promoting compounds.
Research Narrative (Provisional)
Extensive research, including numerous in vitro, animal, and some human clinical studies, supports the broad therapeutic potential of Himalayan Gooseberry (Phyllanthus emblica). Evidence highlights its significant antioxidant, immunomodulatory, hepatoprotective, and adaptogenic properties, particularly due to its rich polyphenol and vitamin C content.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Exceptionally high in Vitamin C, essential for immune support and collagen synthesis. - Phytochemicals: Rich in polyphenols, including flavonoids (e.g., quercetin, kaempferol), ellagitannins, gallic acid, tannins, and betulinic acid, providing potent antioxidant and anti-inflammatory effects. - Minerals: Contains potassium, iron, and calcium, supporting electrolyte balance, oxygen transport, and bone health. - Dietary Fiber: High in prebiotic fiber, promoting digestive health and gut microbiome balance.
Reported Mechanism (Provisional)
The fruit's bioactive compounds inhibit phase I CYP450 enzymes while inducing phase II detoxifying enzymes including GST, NQO1, and superoxide dismutase to block carcinogenesis initiation. Key mechanisms include triggering apoptosis via caspase-3/7/8 activation and DNA fragmentation, reducing inflammation by suppressing IL-6, TNF-α, and COX-2, and activating the Nrf2 antioxidant pathway. The high vitamin C content and polyphenolic compounds like ellagic acid and gallic acid provide potent antioxidant activity while supporting immune cell function.
Clinical Narrative (Provisional)
Clinical research on Himalayan Gooseberry remains limited with most evidence derived from in vitro and animal studies rather than human trials. Preclinical studies demonstrate ethanolic bark extract achieved IC50 52.2 μg/mL for cytotoxicity in cholangiocarcinoma cells and reduced cell migration by 42.5% at 25 μg/mL concentrations. Animal studies show increased hemagglutination antibody titer, leukocyte count, and lymphocyte percentage, though specific sample sizes were not reported. While extensive preclinical evidence supports therapeutic potential, robust human clinical trials with adequate sample sizes are needed to validate efficacy and establish therapeutic dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







